Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Clinical trial NCT07235280 · RECRUITING

Trial details

NCT number: NCT07235280
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Adenocarcinoma Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8 Stage IA2 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8 Lung Cancer

Start date: 2025-12-02
Primary completion: 2028-06-29
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.